30,000 trials. 9 million participants.
20+ years of ground-breaking innovation.

Be at the forefront of clinical trial innovation

Reach critical milestones faster–and deliver patient, site, and sponsor results that move the needle forward for what’s possible in human health.

2,300+ customers and partners. 1,500+ sponsors.

1.5 million users and the largest patient-level

historical clinical trial data set.

We take on trials no one else can

We’re the industry’s only unified platform dedicated to clinical research. Powered by AI insights and the industry’s largest historical patient-level clinical trial data set in the industry that seamlessly connects patients, sites, sponsors, and partners to reach critical milestones faster.

Our continuous innovation is your competitive edge

For nearly 25 years, Medidata has been at the forefront of life science’s digital transformation. Our solutions turn data into insights quickly—on a global scale—creating efficiencies and accelerating innovation while reducing burden on natural resources, trial sites, and participants.

Patient-centric technology, more human experiences

By redefining the capabilities of the entire life science industry, we’re helping our partners move the needle for what’s possible in human health. Our unmatched data–coupled with an unparalleled commitment to patient centricity–enhances trial inclusivity, delivers safer and more effective trial experiences, and helps treatments get to patients faster.

2,100 customers strong + 100 more every quarter

Founded by scientists and engineered for clinical research, we’re a life science organization built exclusively for clinical trial professionals—with a rapidly expanding CRO and sponsor partner base. We bring years of industry-leading expertise across Professional Services, FDA regulation, study start up, R&D, and more with unparalleled customer support to accelerate our customers’ trials and transform their businesses.

Explore how Medidata’s Innovations are Solving Customer Challenges

Decentralized patient centricity

Decentralized patient centricity

Connect every aspect of your clinical trial with the industry’s most comprehensive patient-and-site-facing solutions. Built directly within Medidata’s unified platform, our DCT capabilities and solutions combine leading digital health technologies with unmatched patient centricity.

Here’s how we helped one customer decentralize a trial during a critical moment.

Life-saving data within reach

Life-saving data within reach

Medidata evidence generation helps derive insights and provides answers to study questions – accelerating your path to submission. With powerful AI analytics and data from the world’s largest patient-level historical clinical trial dataset, Medidata has the capabilities you need to reduce uncertainty and improve the success of phase 2 & 3 trials.

Here’s how advanced evidence generation kept a potentially life-saving treatment in the game.

Putting an end to data silos

Putting an end to data silos

Medidata offers next generation clinical data management services and solutions proven to help deliver high-quality data, faster. With a unified platform and support from an award-winning Professional Services team, we help customers streamline manual processes and transform disconnected systems to provide automated delivery of actionable insights.

Here’s how next generation data management accelerated the completion of a complex trial.

Professional Services for Successful Clinical Trials

Our best in class Professional Services team supports your entire clinical trial process with unparalleled industry expertise and award winning customer service.

Experience the difference Medidata support can have on your trial.

1 Analysis of difference in median build time vs matched studies not using professional services (p<0.05)
2 Analysis of difference in median FPI to LPLV time for EDC + at least one additional product vs. EDC only studies (p<0.05)
3 Analysis of difference in median LPLV to DBL time for EDC + at least one additional product vs EDC only studies